Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 11 studies | 48% ± 17% | |
glutamatergic neuron | 10 studies | 70% ± 19% | |
GABAergic neuron | 9 studies | 61% ± 24% | |
astrocyte | 8 studies | 33% ± 18% | |
oligodendrocyte | 8 studies | 36% ± 14% | |
neuron | 6 studies | 51% ± 16% | |
interneuron | 5 studies | 78% ± 16% | |
endothelial cell | 4 studies | 45% ± 23% | |
granule cell | 4 studies | 65% ± 10% | |
microglial cell | 4 studies | 36% ± 17% | |
amacrine cell | 4 studies | 68% ± 11% | |
retina horizontal cell | 4 studies | 63% ± 16% | |
retinal cone cell | 4 studies | 30% ± 10% | |
retinal ganglion cell | 4 studies | 72% ± 14% | |
retinal bipolar neuron | 3 studies | 52% ± 26% | |
GABAergic amacrine cell | 3 studies | 71% ± 13% | |
OFF-bipolar cell | 3 studies | 54% ± 7% | |
ON-bipolar cell | 3 studies | 56% ± 7% | |
glycinergic amacrine cell | 3 studies | 59% ± 11% | |
rod bipolar cell | 3 studies | 61% ± 30% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2643.45 | 2634 / 2642 | 93% | 11.39 | 655 / 705 |
pancreas | 98% | 482.34 | 320 / 328 | 25% | 1.15 | 45 / 178 |
adrenal gland | 24% | 159.36 | 61 / 258 | 74% | 12.01 | 171 / 230 |
kidney | 25% | 88.92 | 22 / 89 | 17% | 0.37 | 157 / 901 |
ovary | 0% | 0 | 0 / 180 | 22% | 0.47 | 96 / 430 |
stomach | 15% | 42.94 | 55 / 359 | 2% | 0.06 | 5 / 286 |
muscle | 15% | 36.61 | 121 / 803 | 0% | 0 | 0 / 0 |
intestine | 9% | 23.02 | 91 / 966 | 2% | 0.08 | 10 / 527 |
uterus | 1% | 5.24 | 2 / 170 | 6% | 0.12 | 29 / 459 |
skin | 0% | 1.50 | 6 / 1809 | 5% | 0.11 | 23 / 472 |
lung | 1% | 1.93 | 4 / 578 | 3% | 0.11 | 37 / 1155 |
eye | 0% | 0 | 0 / 0 | 4% | 0.07 | 3 / 80 |
thymus | 1% | 2.81 | 6 / 653 | 2% | 0.03 | 15 / 605 |
esophagus | 0% | 0.99 | 6 / 1445 | 3% | 0.05 | 5 / 183 |
breast | 0% | 0 | 0 / 459 | 3% | 0.20 | 30 / 1118 |
bladder | 0% | 0 | 0 / 21 | 2% | 0.10 | 9 / 504 |
adipose | 0% | 0.98 | 4 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.74 | 3 / 929 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.06 | 1 / 406 |
heart | 0% | 0.46 | 2 / 861 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0.00 | 1 / 502 |
blood vessel | 0% | 0.51 | 2 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005886 | Cellular component | plasma membrane |
Gene name | UNC79 |
Protein name | Protein unc-79 homolog Unc-79 homolog, NALCN channel complex subunit Protein unc-79 homolog (Unc-79 homolog, NALCN channel complex subunit) |
Synonyms | KIAA1409 |
Description | FUNCTION: Auxiliary subunit of the NALCN sodium channel complex, a voltage-gated ion channel responsible for the resting Na(+) permeability that controls neuronal excitability. Activated by neuropeptides substance P, neurotensin, and extracellular calcium that regulates neuronal excitability by controlling the sizes of NALCN-dependent sodium-leak current. . |
Accessions | ENST00000627404.2 [Q9P2D8-1] ENST00000553484.5 [Q9P2D8-3] ENST00000627695.2 [Q9P2D8-2] A0A8Q3SHN5 ENST00000555664.5 ENST00000615108.1 [Q9P2D8-2] ENST00000695012.1 G3V2U4 ENST00000695013.1 ENST00000629588.2 [Q9P2D8-3] Q9P2D8 A0A8Q3SHI5 ENST00000393151.6 [Q9P2D8-1] ENST00000256339.8 [Q9P2D8-2] ENST00000629205.2 ENST00000621021.1 [Q9P2D8-2] |